
Efferon selected for TechCrunch Disrupt with device for children with sepsis
Efferon says its devices absorb endotoxins and cytokines at the same time. CEO Dima Romashin contrasts this with other devices on the market. The company’s
Oct 11, 20262 min read0 reactions0 comments